EOSINOPHIL PERCENTAGE INCREASED side effect
What is EOSINOPHIL PERCENTAGE INCREASED ?Drugs associated with EOSINOPHIL PERCENTAGE INCREASED
CITALOPRAM LANSOPRAZOLE NAMENDA OMALIZUMAB TAZOCIN TEKTURNA XOPENEXEOSINOPHIL PERCENTAGE INCREASED : Tazocin Side Effects Report #5671966-7
Health Professional from JAPAN reported TAZOCIN problem on Mar 12, 2008. Female patient, weighting 121.3 lb, was diagnosed with cholecystitis, fluid replacement, nutritional support and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, interstitial lung disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ELECTROLYTE SOLUTIONS, VITAMINS NOS, ASCORBIC ACID, RIBOFLAVIN, THIAMINE DISULFIDE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B. Patient was hospitalized. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Tazocin Side Effects Report #5627413-4
TAZOCIN problem was reported by a Health Professional from JAPAN on Feb 08, 2008. Female patient, weighting 121.3 lb, was diagnosed with cholecystitis and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, interstitial lung disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ELECTROLYTE SOLUTIONS, VITAMINS NOS, ASCORBIC ACID, RIBOFLAVIN, THIAMINE DISULFIDE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B. Patient was hospitalized. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Citalopram Side Effects Report #5642290-3
Consumer or non-health professional from GERMANY reported CITALOPRAM HYDROBROMIDE problem on Feb 11, 2008. Female patient, 21 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, hypersensitivity, leukopenia, neutrophil count decreased, platelet count decreased, rash macular, treatment noncompliance, viral infection, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, LAMICTAL. Patient was hospitalized. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Lansoprazole Side Effects Report #5613994-3
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2008. Male patient, 84 years of age, was diagnosed with gastric haemorrhage and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, . LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with FULCALIQ 2, MINERALIN, LASIX. Patient died.
EOSINOPHIL PERCENTAGE INCREASED : Namenda Side Effects Report #5590861-5
Health Professional from UNITED STATES reported NAMENDA problem on Oct 18, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with NAMENDA. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, ileus, lymphocyte percentage decreased, rash pruritic, red blood cell morphology abnormal, . NAMENDA dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, ACETAMINOPHEN, ZOLOFT, LOPRESSOR, LOMOTIL, NEXIUM, REGLAN, WELCHOL. Patient was hospitalized. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Omalizumab Side Effects Report #5506589-3
OMALIZUMAB problem was reported by a Physician from UNITED STATES on Oct 29, 2007. Female patient, weighting 217.4 lb, was diagnosed with asthma and was treated with OMALIZUMAB. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, rash, . OMALIZUMAB dosage: unknown. During the same period patient was treated with PREDNISONE, FOSAMAX, POTASSIUM CHLORIDE, SINGULAIR. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Tekturna Side Effects Report #5488505-6
Physician from UNITED STATES reported TEKTURNA problem on Aug 22, 2007. Female patient was diagnosed with hypertension and was treated with TEKTURNA. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, neoplasm malignant, . TEKTURNA dosage: unknown. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Xopenex Side Effects Report #5382913-X
XOPENEX HFA problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX HFA. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased, . XOPENEX HFA dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
EOSINOPHIL PERCENTAGE INCREASED : Xopenex Side Effects Report #5382913-X
Physician from UNITED STATES reported XOPENEX HFA problem on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX HFA. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased, . XOPENEX HFA dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.